By Elise Craig | December 27, 2019
Over the course of 2019 alone, investors have put more than $150 million into companies like Modern Fertility and EverlyWell, which make at-home fertility-testing kits for women (each $159); Dadi, which provides sperm testing, freezing and storage (starting at $99; see sidebar); as well as start-ups like Kindbody, which are trying to make the egg-freezing process — and its pricing — more transparent (consultations are $300). There are also companies working with employers to offer fertility benefits, like Carrot Fertility. CB Insights, a company that tracks business trends, pegs the global market for fertility at $25 billion.
To read the full article visit www.nytimes.com.